Two Qatari siblings with cystic fibrosis and apparent mineralocorticoid excess

Annals of Thoracic Medicine

Volumn 10, Issue 1, 2015, Pages 69-72

  Zahraldin, Khalid ^a   Janahi, Ibrahim Ahmed ^a   Ben Omran, Tawfeg ^b   Alsulaiman, Reem ^b   Hamad, Bajes ^a   Imam, Abubakr ^a  

^a HAMAD MEDICAL CORPORATION   (Qatar)

^b Section of Clinical and Metabolic Genetics   (Qatar)

Author keywords

Apparent mineralocorticoid excess; Arab; autosomal recessive; cystic fibrosis; Qatar

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; CHLORIDE CHANNEL; CORTISONE; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR;

11BETAHSD2 GENE; APPARENT MINERALOCORTICOID EXCESS SYNDROME; ARAB; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CFTR GENE; CHILD; CONSANGUINEOUS MARRIAGE; CYSTIC FIBROSIS; FEMALE; GENE; GENE MUTATION; GENETIC COUNSELING; HUMAN; HYPERTENSION; HYPOKALEMIA; INFANT; MALE; QATARI; SIBLING; SODIUM RETENTION;

EID: 84919968844     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: 10.4103/1817-1737.146892     Document Type: Article

References (16)

1. Teebi AS, El-Shanti HI. Consanguinity: Implications for practice, research, and policy. Lancet 2006;367:970-1.
2. White PC, Mune T, Agarwal AK. 11beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 1997;18:135-56.
3. Luft FC. Mendelian forms of human hypertension and mechanisms of disease. Clin Med Res 2003;1:291-300.
4. Morineau G, Sulmont V, Salomon R, Fiquet-Kempf B, Jeunamaitre X, Nicod J, et al. Apparent mineralocorticoid excess: Report of six new cases and extensive personal experience. J Am Soc Nephrol 2006;17:3176-84.
5. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 1994;105:R11-7.
6. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, et al. Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 1989;245:1059-65.
7. Funder J, Myles K. Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: In vivo binding studies. Endocrinology 1996;137:5264-8.
8. Al-Harbi T, Al-Shaikh A. Apparent mineralocorticoid excess syndrome: Report of one family with three affected children. J Pediatr Endocrinol Metab 2012;25:1083-8.
9. Wilson RC, Nimkarn S, New MI. Apparent mineralocorticoid excess. Trends Endocrinol Metab 2001;12:104-11.
10. Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration 2000;67:1170-33.
11. Edwards CR Benediktsson R, Lindsay RS, Seckl JR. Dysfunction of the placental glucocorticoid barrier: Link between fetal environmental and hypertension? Lancet 1993;341:355-7.
12. Craigie E, Evans LC, Mullins JJ, Bailey MA. Failure to down regulate the epithelial sodium channel causes salts sensitivity in hsd11b2 heterozygote mice. Hypertension 2012;60:684-90.
13. Knops NB, Monnens LA, Lenders JW, Levtchenko EN. Apparent mineralocorticoid excess: Time of manifestation and complications despite treatment. Pediatrics 2011;127:e1610-4.
14. Quinkler M, Bappal B, Draper N, Atterbury AJ, Lavery GG, Walker EA, et al. Molecular basis for the apparent mineralocorticoid excess syndrome in the Oman population. Mol Cell Endocrinol 2004;217:143-9.
15. Paolo F, Zygmunt K. Mineralocorticoid Selectivity: Role of 11 βHSD2 and Other Mechanism. Kidney Int 2000;57:1374-81.
16. Draper N, Stewart PM. 11beta-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J Endocrinol 2005;186:251-71.